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Bioimaging and in vivo imaging are cornerstone technologies in support of 
biomedical diagnosis. However, in some cases imaging methods have increased 
cancer risks for patients. Moreover, the most widely used diagnostic medical 
imaging technique, X-ray imaging, is the largest man-made source of radiation 
exposure to the general population. Thus, the research of new efficient and less 
invasive materials for imaging is quite urgent. 
Supramolecular hydrogels have recently proved to be promising biological 
carriers to load versatile bioimaging agents for in vitro or in vivo bioimaging, thanks 
to the ability to undergo reversible swelling and gel–sol transition in response to 
various physiological stimuli. In addition, the biodegradability and biocompatibility 
allowed the use of supramolecular gels also for cancer diagnosis, as they can be 
facilely endocytosed into cells [1]. 
Remembering the good biological response of some imidazolium derived 
hydrogels [2], fluorescent imidazolium organic salts, that should own the double 
function of gelator and bioimaging agent, have been synthesized. 
New fluorescent hydrogels with interesting physico-chemical properties 
(rheology, gel-sol temperature transition and optical properties) have been tested 
for anti-proliferative activity, in vitro bioimaging on cancer cells and controlled 
release of gelator in physiological medium. Results evidence how these hydrogels 
can be potentially investigated as new theranostic media for anticancer research.  
 
Figure 1: Gelator structure and bioimaging on cancer cells. 
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